Posted on 5/17/17
Decibel Therapeutics Opens New Headquarters and The Fenway’s First Lab
BOSTON--(BUSINESS WIRE)--Decibel Therapeutics, a company focused on discovering and developing new medicines to protect, repair and restore hearing, today moved into its new headquarters and lab . . .
Posted on 5/17/17
ProEx Physical Therapy Appoints Brandon Drinan as Exercise Technician
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces
Posted on 5/17/17
Better Buy: Veeva Systems Inc. vs. athenahealth
Explosive revenue growth proves athenahealth, Inc. (NASDAQ:ATHN) and Veeva Systems Inc. (NYSE:VEEV) can pull their target markets into the cloud fast enough to reward shareholders with . . .
Posted on 5/17/17
WEGO Health Partners with CureClick
WEGO Health, a network of more than 100,000 patient leaders, today announced it has partnered with CureClick to make patient influencers available through the CureClick clinical . . .
Posted on 5/17/17
X-Chem and Vertex Enter into Multi-Target Genetic Disease Collaboration
WALTHAM, Mass.--(BUSINESS WIRE)--X-Chem, Inc. (X-Chem), a privately held biotechnology company applying its innovative drug discovery platform to the generation of novel small molecule therapeutics, today announced . . .
Posted on 5/16/17
3 Biotech Stocks I'd Buy Right Now
Biotech stocks across the board have had a great year so far, but Cara Therapeutics Inc.(NASDAQ:CARA), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), and Omeros Corporation (NASDAQ:OMER) have flown . . .
Posted on 5/16/17
Veristat Acknowledged on Boston Business Journal’s “Fast 50” List for a Second Consecutive Year
SOUTHBOROUGH, Mass.--(BUSINESS WIRE)--Veristat, a full service Clinical Research Organization (CRO), announced today that it has been recognized for a second consecutive year as one of the . . .
Posted on 5/15/17
AMAG Pharmaceuticals Completes Financing Transactions
WALTHAM, Mass., May 15, 2017 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that it has paid in full the remaining balance of $321 million . . .
Posted on 5/15/17
Aldeyra Therapeutics Provides Corporate Update
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a clinical-stage biotechnology company devoted to treating inflammation, inborn errors of metabolism, and other diseases related to aldehydes, today provided . . .
Posted on 5/15/17
Why You're Smart to Buy Cara Therapeutics Stock
Cara Therapeutics (NASDAQ:CARA) isn't profitable and probably won't be for quite a while. The company lost over $27 million in the first quarter. It doesn't have . . .
Posted on 5/15/17
3 Stocks Warren Buffett Can't Buy, but You Can
As arguably the world's most successful stock picker, it's no surprise that Warren Buffett is watched closely by investors around the world. At the end of . . .
Posted on 5/15/17
CVS Health To Present At The UBS Global Healthcare Conference
CVS Health Corporation (NYSE: CVS) today announced that Larry Merlo, the company's president and chief executive officer, will be speaking to investors at the UBS Global . . .
Posted on 5/15/17
Alnylam Pharmaceuticals Reports Inducement Grant to CFO Manmeet S. Soni
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that it has granted stock options to Manmeet S. Soni, the Company's . . .
Posted on 5/12/17
Biostage, Inc. 2017 Q1 - Results - Earnings Call Slides
The following slide deck was published by Biostage, Inc. in conjunction with their 2017 Q1 earnings call. 19READ FULL ARTICLE HERE
Posted on 5/11/17
NeuroMetrix Announces One-for-Eight Reverse Split
BOSTON--(BUSINESS WIRE)--NeuroMetrix, Inc. (NASDAQ:NURO) today announced a one-for-eight reverse split of its common stock effective as of Thursday, May 11, 2017. The shares underlying the Company's . . .
Posted on 5/11/17
Bristol-Myers Squibb: A Deep Dive Finds Some Pearls
IntroductionIt's one thing to speculate on takeovers. It's another to have a takeover merely as a kicker, with a strong company and a reasonably valued stock. . . .
Posted on 5/11/17
Charles River Laboratories International (CRL) Q1 2017 Results - Earnings Call Transcript
Charles River Laboratories International, Inc. (NYSE:CRL)Q1 2017 Earnings CallMay 10, 2017 8:30 am ETExecutivesSusan E. Hardy - Charles River Laboratories International, Inc.James C. Foster - Charles . . .
Posted on 5/9/17
Here's Why athenahealth, Inc. Fell 13% in April
What happenedShares of athenahealth, Inc. (NASDAQ:ATHN) a provider of network-enabled services for healthcare providers, fell 13% in April, according to data from S&P Global Market Intelligence. . . .
Posted on 5/9/17
Here's Why Vertex Pharmaceuticals Incorporated Gained 8% in April
What happenedShares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) a biopharma company focused on treating cystic fibrosis, rose 8.18% in April according to data from S&P Global Market . . .
Posted on 5/9/17
AVEO Oncology Announces Receipt of USPTO Notice of Allowance Related to AV-353
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ: AVEO) today announced that it received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. . . .
Posted on 5/8/17
Jeanine Jernegan, PT of Peak Physical Therapy & Sports Performance Earns Certification in dry Needling Therapy
Peak Physical Therapy & Sports Performance, a South Shore practice specializing in unique programs that provides comprehensive treatment in orthopedic, spine and sports medicine specialties, announces . . .
Posted on 5/8/17
Acceleron Pharma Reports First Quarter 2017 Operational and Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics to treat serious and rare . . .
Posted on 5/8/17
Why Did Cara Therapeutics Shares Tumble 13.6% in April?
What happenedFollowing a stock offering that diluted investors and ahead of first-quarter financial results, shares in Cara Therapeutics (NASDAQ:CARA) lost 13.6% of their value in April, . . .
Posted on 5/8/17
Why Biogen Inc. Shareholders Have Something to Worry About
Biogen (NASDAQ:BIIB) has gotten off to a great start in 2017 in some respects. The biotech launched promising new spinal muscular atrophy drug (SMA) Spinraza. The . . .
Posted on 5/8/17
PureTech Health Announces Licensing Agreement between Commense and the University of British Columbia
BOSTON--(BUSINESS WIRE)--PureTech Health plc, an advanced, clinical-stage biopharmaceutical company, is pleased to announce a licensing agreement between Commense, Inc., a subsidiary of PureTech Health, and the . . .
Boston
